ECOG-ACRIN research highlights at ASCO 2021

(ECOG-ACRIN Cancer Research Group) Platinum chemotherapy fails for triple-negative breast cancer, basal-like subtype. The first racially diverse trial to look at severe joint pain from aromatase inhibitors shows more postmenopausal Black and Asian women with early breast cancer developed this common/significant syndrome. Less intense therapy for HPV-associated throat cancer shows outstanding three-year survival and quality of life. Inflammation biomarker links to distant recurrence of HER2-negat...